Immunovant shares surge after antibody treatment succeeds in early-stage study
Reuters· 44 分鐘前Shares of Immunovant (IMVT.O) surged over 60% in premarket trading on Tuesday, after data from an early-stage ...
Cough syrup deaths overseas prompt US crackdown on toxic testing
Reuters· 3 小時前The U.S. FDA is cracking down on lax testing practices by dozens of makers of healthcare ... ...
FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative
Forbes· 6 日前The rejection came despite FDA advisors voting in favor of the regulator approving ...
European markets close lower on prospect of higher for longer rates; AstraZeneca up after ...
CNBC· 4 日前a fall of 1.1% in July. Food stores sales volumes increased by 1.2% after a fall of ... ...
The elusive Fed 'soft landing' nears. Why are Americans so mad about the economy? ...
Reuters· 4 小時前The central bank's quest for a "soft landing" of more slowly rising prices and ...
Health care has had a tough year. Where we stand on our 5 stocks in the sector
CNBC· 4 日前Of the 11 market sectors year to date, health care is the fourth ...
PDS is coming to a cop car near you to stop you from drug-driving
TechCrunch· 6 日前In 2020, there were more than 5 million car accidents reported to the police — that’s about one ...
China healthcare a unique multidecade investment bet
China Daily· 1 日前The recent monetary and fiscal stimulus measures introduced by the central and local ... ...
Ypsomed signs autoinjector supply deal with Novo Nordisk
Reuters· 5 日前Swiss medical technology company Ypsomed (YPSN.S) announced on Wednesday a long-term ... ...
Scynexis to recall GSK-partnered antifungal on cross contamination risk
Reuters· 22 小時前Scynexis (SCYX.O) said on Monday it would voluntarily recall its antifungal pill, which it has licensed ...
